Richard B. Greenwald

3.1k citations
49 papers · 2.5k indexed · 2 hit papers · h-index 20
Topics
Chemical Synthesis and Analysis (9 papers)Cancer Treatment and Pharmacology (9 papers)Cancer therapeutics and mechanisms (7 papers)
Partner nations
United States

In The Last Decade

Richard B. Greenwald

48 papers receiving 2.3k citations

Hit Papers

Effective drug delivery by PEG...196320261984200520031963200400600

Peers

Richard B. Greenwald
Comparison fields: 5 of 111
  • Molecular Biology 1.2k
  • Organic Chemistry 917
  • Biomaterials 722
  • Oncology 437
  • Biomedical Engineering 367
Replace Oddone Schiavon with:
Oddone Schiavon Italy
Yun H. Choe South Korea
T. van Es United States
Charles D. Conover United States
V.P. Torchilin Russia
Hamidreza Montazeri Aliabadi United States
Abdullah Mahmud Canada
Geneviève Gaucher Canada
Jean d’Angelo France
Fergal Davis United States
Richard B. Greenwald relative to Oddone Schiavon Italy Oddone Schiavon's profile →
Citations per field
00.5×1.6×
Oddone Schiavon · 1×
Citations per year

Countries citing papers authored by Richard B. Greenwald

Since Specialization
Citations

This map shows the geographic impact of Richard B. Greenwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Greenwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Greenwald more than expected).

Fields of papers citing papers by Richard B. Greenwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Greenwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Greenwald. The network helps show where Richard B. Greenwald may publish in the future.

Co-authorship network of co-authors of Richard B. Greenwald

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Greenwald. A scholar is included among the top collaborators of Richard B. Greenwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Greenwald. Richard B. Greenwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 4
3
Effective drug delivery by PEGylated drug conjugatesbreakdown →
721
4 16
5 14
6 59
7 2
8 20
9 104
10 33
11 102
12 182
13 8
14 91
15 3
16 0
17 5
18 10
19 9
20
The Wittig Reaction Using Methylsulfinyl Carbanion-Dimethyl Sulfoxide 1breakdown →
300

About Richard B. Greenwald

Richard B. Greenwald is a scholar working on Organic Chemistry, Biomaterials and Oncology, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (9 papers), Cancer Treatment and Pharmacology (9 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Biomaterials (722 citations), Organic Chemistry (917 citations) and Pharmaceutical Science (187 citations). Richard B. Greenwald has collaborated with scholars based in United States. Frequent co-authors include Charles D. Conover, Yun H. Choe, Jeffrey M. McGuire, Annapurna Pendri, E. J. Corey, Michael Chaykovsky, Hong Zhao, Carl W. Gilbert, Anthony Martinez and Kwok Shum. Their work appears in journals such as Journal of the American Chemical Society, Advanced Drug Delivery Reviews and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026